Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 10

1.

Selective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention Trial.

Williams SB, Salami S, Regan MM, Ankerst DP, Wei JT, Rubin MA, Thompson IM, Sanda MG.

Cancer. 2012 May 15;118(10):2651-8. doi: 10.1002/cncr.26396. Epub 2011 Oct 17.

2.

Watchful waiting for localized prostate cancer in the PSA era: what have been the triggers for intervention?

Coen JJ, Feldman AS, Smith MR, Zietman AL.

BJU Int. 2011 May;107(10):1582-6. doi: 10.1111/j.1464-410X.2010.09652.x. Epub 2010 Sep 22.

3.

Risk stratification of men choosing surveillance for low risk prostate cancer.

Tseng KS, Landis P, Epstein JI, Trock BJ, Carter HB.

J Urol. 2010 May;183(5):1779-85. doi: 10.1016/j.juro.2010.01.001. Epub 2010 Mar 20.

4.

Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.

Stephenson AJ, Kattan MW, Eastham JA, Bianco FJ Jr, Yossepowitch O, Vickers AJ, Klein EA, Wood DP, Scardino PT.

J Clin Oncol. 2009 Sep 10;27(26):4300-5. doi: 10.1200/JCO.2008.18.2501. Epub 2009 Jul 27.

5.

Pretreatment predictors of death from other causes in men with prostate cancer.

Simone NL, Singh AK, Cowan JE, Soule BP, Carroll PR, Litwin MS.

J Urol. 2008 Dec;180(6):2447-51; discussion 2451-2. doi: 10.1016/j.juro.2008.08.017. Epub 2008 Oct 19.

6.

PSA doubling time versus PSA velocity to predict high-risk prostate cancer: data from the Baltimore Longitudinal Study of Aging.

Loeb S, Kettermann A, Ferrucci L, Landis P, Metter EJ, Carter HB.

Eur Urol. 2008 Nov;54(5):1073-80. doi: 10.1016/j.eururo.2008.06.076. Epub 2008 Jul 2.

7.

Low risk prostate cancer in men under age 65: the case for definitive treatment.

Jang TL, Yossepowitch O, Bianco FJ Jr, Scardino PT.

Urol Oncol. 2007 Nov-Dec;25(6):510-4. Review.

8.

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience.

Carter HB, Kettermann A, Warlick C, Metter EJ, Landis P, Walsh PC, Epstein JI.

J Urol. 2007 Dec;178(6):2359-64; discussion 2364-5. Epub 2007 Oct 22.

9.
10.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk